Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C Virus Genotype 1”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00686777
What this trial is testing

Pegylated Interferon (PEG-IFN) Alfa-2b and Low Dose Ribavirin for the Treatment of Chronic Hepatitis C Patients With Genotype 1 High Viral Load and Low Body Weight (Study P05172)(COMPLETED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 75
Testing effectiveness (Phase 2)Study completedNCT02133131
What this trial is testing

Efficacy and Safety of Grazoprevir (MK-5172), Elbasvir (MK-8742), and Sofosbuvir for Chronic Infection With Hepatitis C Virus Genotypes 1 and 3 (MK-5172-074)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 143
Large-scale testing (Phase 3)Study completedNCT02114177
What this trial is testing

Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Chronic Hepatitis C Virus Infection Without Cirrhosis

Who this might be right for
Hepatitis C Virus Infection
Janssen Infectious Diseases BVBA 310
Testing effectiveness (Phase 2)Study completedNCT00968357
What this trial is testing

Proof-of-concept Study to Evaluate the Safety and Immunomodulatory Effects of SCV 07 as Monotherapy or in Combination With Ribavirin in Noncirrhotic Subjects With Chronic Hepatitis C Who Have Relapsed

Who this might be right for
Chronic Hepatitis C
SciClone Pharmaceuticals 40
Testing effectiveness (Phase 2)Study completedNCT00807001
What this trial is testing

Double-Blind, Dose-Escalation Study of IDX184 in Chronic Hepatitis C Treatment-Naïve Subjects

Who this might be right for
Chronic Hepatitis C (HCV)
Merck Sharp & Dohme LLC 41
Testing effectiveness (Phase 2)Study completedNCT01724086
What this trial is testing

Evaluate the Safety, Tolerability, and Effectiveness of a 12-Week Combination Therapy of TMC647055 and TMC435 With and Without GSK23336805 With a Pharmacokinetic Enhancer With and Without Ribavirin in Patients Infected With Chronic Genotype 1 Hepatitis C Virus

Who this might be right for
Chronic Hepatitis C
Janssen R&D Ireland 90
Early research (Phase 1)Study completedNCT00372983
What this trial is testing

Safety and PK Study of NOV-205 to Treat Chronic HCV Who Fail Standard Therapy

Who this might be right for
Hepatitis C
Cellectar Biosciences, Inc. 30
Not applicableStudy completedNCT03303599
What this trial is testing

Study of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C Genotypes 1 to 6

Who this might be right for
Hepatitis C
AbbVie 2,118
Early research (Phase 1)WithdrawnNCT01525212
What this trial is testing

Multiple Ascending Dose Study of BMS-929075 in Hepatitis C Virus (HCV) Infected Patients

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb
Large-scale testing (Phase 3)Study completedNCT02060058
What this trial is testing

Boceprevir-based Therapy to Rescue HCV Genotype 1/HBV Infected Patients Refractory to Combination Therapy

Who this might be right for
Hepatitis C, Chronic
Kaohsiung Medical University Chung-Ho Memorial Hospital 12
Testing effectiveness (Phase 2)Study completedNCT01984294
What this trial is testing

Ledipasvir/Sofosbuvir Fixed-Dose Combination With Ribavirin or GS-9669 in Subjects With Chronic Genotype 1 HCV Infection

Who this might be right for
Chronic HCV Infection
Gilead Sciences 101
Large-scale testing (Phase 3)Study completedNCT00705432
What this trial is testing

Safety and Efficacy of Boceprevir in Previously Untreated Subjects With Chronic Hepatitis C Genotype 1 (Study P05216AM2) (COMPLETED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 1,472
Post-approval studies (Phase 4)Study completedNCT00202839
What this trial is testing

Peg-Intron/Ribavirin in G 1 HCV for Non-Extended Versus 24 Week Extended Treatment After 24 Weeks (Study P04144)(COMPLETED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 160
Testing effectiveness (Phase 2)Study completedNCT02332707
What this trial is testing

Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Genotype (GT)1 and GT2 Infection (MK-3682-011)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 443
Post-approval studies (Phase 4)Study completedNCT01222611
What this trial is testing

HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir

Who this might be right for
Chronic HIV InfectionHCV Coinfection
Fundacion SEIMC-GESIDA 42
Post-approval studies (Phase 4)Study completedNCT00546442
What this trial is testing

Treatment Insulin Resistence in HCV G-1 Patient

Who this might be right for
Chronic Hepatitis C
Valme University Hospital 126
Not applicableStudy completedNCT01310205
What this trial is testing

Extension Study SCI-SCV-HCV-P2-001: Long-Term FU in Subj Who Opt for Retreatment With Peg-INF and RBV After Completing Treatment in HCV

Who this might be right for
Chronic Hepatitis C
SciClone Pharmaceuticals 12
Post-approval studies (Phase 4)Study completedNCT02461745
What this trial is testing

Real World Study: Genotype 1 Chronic Hepatitis C Virus Treatment and Evaluation of Real World SVR and PRO

Who this might be right for
Hepatitis C, Chronic
Kaiser Permanente 200
Early research (Phase 1)Study completedNCT01448200
What this trial is testing

PPI-668 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) Genotype 1

Who this might be right for
Hepatitis C, Chronic
Presidio Pharmaceuticals, Inc. 82
Testing effectiveness (Phase 2)Study completedNCT01331850
What this trial is testing

Danoprevir/Ritonavir and Copegus With RO5024048 and/or Pegasys in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 381
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation